
    
      A European prospective, randomized, double-blind, multicentre, clinical trial, conducted in
      three parallel groups, to evaluate the efficacy and safety of a device with LU3103209
      compound versus the same device, free of LU3103209 compound, in the local management of
      diabetic foot ulcers (DFUs).
    
  